Côte d'Ivoire vs Poland: New cases tested for RR-/MDR-TB
Côte d'Ivoire
86.0%
in 2024
Poland
85.0%
in 2024
Côte d'Ivoire rank
115th
Poland rank
118th
New cases tested for RR-/MDR-TB over time
- Côte d'Ivoire
- Poland
How they compare
Côte d'Ivoire currently reports 86.0% against 85.0% in Poland, a difference of 1.0%.
The two have swapped places 1 time across 17 shared years of data; in 2005 it was Poland ahead.
Côte d'Ivoire ranks 115th and Poland ranks 118th of 192 countries.
Poland has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Côte d'Ivoire | Poland | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 0.0% | 88.3% | 88.3% | Poland |
| 2010s | 11.7% | 89.6% | 77.9% | Poland |
| 2020s | 57.2% | 88.2% | 31.0% | Poland |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher new cases tested for rr-/mdr-tb, Côte d'Ivoire or Poland?
- Côte d'Ivoire, at 86.0% against 85.0% in Poland as of 2024.
- What is the difference in new cases tested for rr-/mdr-tb between Côte d'Ivoire and Poland?
- 1.0%, with Côte d'Ivoire ahead.
- How many years of comparable data are there for Côte d'Ivoire and Poland?
- 17 years are reported by both, from 2005 to 2024.
- How do Côte d'Ivoire and Poland rank globally for new cases tested for rr-/mdr-tb?
- Côte d'Ivoire ranks 115th and Poland ranks 118th of 192 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as New cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.